Cell and gene therapy
Statistics report about the cell and gene therapy industry
This report presents key facts and figures about the cell and gene therapy industry. Cell and gene therapies are especially well-known in the treatment of cancer. The report provides information on the total market and submarkets, regional distribution, the cord blood bank system, forecasts, etc.
Report Details
Cell and gene therapy
Pages
39 Pages
Format
PPTX
,
PDF
Language
English
Released
2018
Access
Download from this page
Price
Old price: $495 USD New price: $345 USD
Comprehensive data insights
Includes all relevant statistics
Compiled by our industry experts
Table of contents
Market overview
6
Basic
Statistic
Global market size for regenerative medicine 2022-2032
Premium
Statistic
Global cell and gene therapy manufacturing market forecast 2023-2034
Basic
Statistic
Global cell culture market size 2022-2030
Premium
Statistic
ATMP classification share worldwide 2016
Basic
Statistic
Regenerative medicine companies by world region Q3 2025
Basic
Statistic
Market cap of gene and cell therapy companies 2026
R&D/trials
5
Premium
Statistic
ATMP trials classification share by disease and development phase globally 2016
Premium
Statistic
ATMP clinical trials share globally by type of sponsor 2016
Premium
Statistic
ATMP clinical trials non-commercial sponsors distribution globally 2016
Premium
Statistic
Number of biotech therapies in development as of 2017, by developer
Basic
Statistic
Percentage of biotech therapies in development as of 2017, by developer
Stem cells
5
Premium
Statistic
Global stem cell market size by world region 2011-2016
Premium
Statistic
Stem cell technologies and applications market share by world region 2016
Premium
Statistic
Global stem cell therapy market size forecast 2022-2032
Premium
Statistic
Number of HSC transplants in the US from 2010-2015, by source
Premium
Statistic
Total stem cell research funding by the National Institutes of Health 2013-2024
Cord blood
5
Basic
Statistic
Aggregate annual demand for cord blood units from 2010-2016
Premium
Statistic
Annual social value of U.S. CBB system by scenario 2010-2016
Premium
Statistic
Percentage of CBUs from the U.S. shipped domestically and internationally 2010-2016
Basic
Statistic
Percentage of shipped U.S. cord blood units by TNC count 2002-2016
Premium
Statistic
Percentage of stored U.S. CBUs by TNC count 2002-2016
CAR/CAR-T
4
Basic
Statistic
Number of CAR cell therapy trials worldwide 2007-2016
Basic
Statistic
Number of CAR cell therapy trials U.S. vs China 2009-2016
Basic
Statistic
Venture capital funding for companies in CAR-T programs 2011-2016
Basic
Statistic
IPO value of select CAR-T companies 2013-2015
Miscellaneous
5
Basic
Statistic
Length of hospital stay for an HSC transplant in the U.S. in 2014, by procedure
Premium
Statistic
Medicaid charges and costs for an HSC transplant in the U.S. in 2014, by procedure
Premium
Statistic
Capital raised by regenerative medicine companies worldwide 2016-2023
Basic
Statistic
Select market-stage ATMPs price in the U.S. as of 2016
Premium
Statistic
View of increasing government funding for stem cell research - U.S. adults 2017
FURTHER REPORTS
Recommended and recent reports
Recommended statistics
You may also be interested in...